Development and validation of a new nomogram to screen for MAFLD

BACKGROUND AND AIM: Metabolic dysfunction-associated fatty liver disease (MAFLD) poses significant health and economic burdens on all nations. Thus, identifying patients at risk early and managing them appropriately is essential. This study’s goal was to develop a new predictive model for MAFLD. Add...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Haoxuan, Zhao, Fanrong, Lv, Xiuhe, Ma, Xiaopu, Xie, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730620/
https://www.ncbi.nlm.nih.gov/pubmed/36482400
http://dx.doi.org/10.1186/s12944-022-01748-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730620/
https://www.ncbi.nlm.nih.gov/pubmed/36482400
http://dx.doi.org/10.1186/s12944-022-01748-1

Ejemplares similares